Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells
- First Online:
- Cite this article as:
- Lin, M., Chen, Y., Jin, J. et al. Diabetologia (2011) 54: 1554. doi:10.1007/s00125-011-2081-0
- 1.1k Views
Retinal Müller cells are known to produce inflammatory and angiogenic cytokines, which play important roles in diabetic retinopathy. Hypoxia-inducible factor (HIF)-1 has been shown to play a crucial role in retinal inflammation and neovascularisation. We sought to determine the role of Müller cell-derived HIF-1 in oxygen-induced retinopathy (OIR) and diabetic retinopathy using conditional Hif-1α (also known as Hif1a) knockout (KO) mice.
Conditional Hif-1α KO mice were generated by crossing mice expressing cyclisation recombinase (cre, also known as P1_gp003) in Müller cells with floxed Hif-1α mice and used for OIR and streptozotocin-induced diabetes to induce retinal neovascularisation and inflammation, respectively. Abundance of HIF-1α and pro-angiogenic and pro-inflammatory factors was measured by immunoblotting and immunohistochemistry. Retinal neovascularisation was visualised by angiography and quantified by counting pre-retinal nuclei. Retinal inflammation was evaluated by leucostasis and vascular leakage.
While the Hif-1α KO mice showed significantly decreased HIF-1α levels in the retina, they exhibited no apparent histological or visual functional abnormalities under normal conditions. Compared with wild-type counterparts, Hif-1α KO mice with OIR demonstrated attenuated overproduction of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule (ICAM)-1, reduced vascular leakage and alleviated neovascularisation in the retina. Under diabetes conditions, disruption of Hif-1α in Müller cells attenuated the increases of retinal vascular leakage and adherent leucocytes, as well as the overproduction of VEGF and ICAM-1.
Müller cell-derived HIF-1α is a key mediator of retinal neovascularisation, vascular leakage and inflammation, the major pathological changes in diabetic retinopathy. Müller cell-derived HIF-1α is therefore a promising therapeutic target for diabetic retinopathy.
KeywordsAngiogenesisDiabetic retinopathyHypoxiaIschaemiaMüller cellsRetina
Intercellular adhesion molecule
Vascular endothelial growth factor
von Hippel–Lindau tumour-suppressor protein
Angiogenesis is an important physiological process in development and wound healing . It is well known that angiogenesis is controlled by a delicate balance of pro-angiogenic and anti-angiogenic factors in tissues . Dysregulation of this balance has been shown to result in pathological angiogenesis such as diabetic retinopathy and cancer . Extensive studies have shown that oxygen-sensing systems play important roles in maintaining the balance of angiogenesis regulation. Hypoxia-inducible factor (HIF)-1 is a key oxygen sensor and mediator of angiogenesis [3–5].
HIF-1 is a heterodimer consisting of an O2-regulated HIF-1α subunit and a constitutive HIF-1β subunit . Under normoxia, HIF-1α is constantly synthesised and degraded. The degradation of HIF-1α is triggered by binding of the von Hippel–Lindau tumour-suppressor protein (VHL). As VHL interacts with the protein Elongin C, recruits an E3 ubiquitin-protein ligase complex and ubiquitinates HIF-1α, HIF-1α is degraded by the 26 S proteasome [7, 8]. VHL binding is dependent on hydroxylation of Pro402 or Pro564, or both, by a dioxygenase called the prolyl hydroxylase domain protein 2 [9, 10]. However, activity of this dioxygenase decreases under hypoxic conditions [11–13]. Therefore, HIF-1α is accumulated, dimerises with HIF-1β, is transported into the nucleus and binds to the hypoxia-responsive elements in the promoters of target genes, such as those encoding vascular endothelial growth factor (VEGF) and erythropoietin, which are key pro-angiogenic factors and pathogenic factors in diabetic retinopathy .
Retinal Müller cells are the principal supporting cells in the neural retina and participate in retinal angiogenesis, neural protection and other physiological functions [15, 16]. Recent studies have indicated that HIF-1α is produced in all of the retinal layers . Under hypoxic conditions, HIF-1α, VEGF and erythropoietin levels increase rapidly in the inner retina, particularly in a central region of the inner nuclear layer, where Müller cell nuclei are located. The finding that disruption of Müller cell-derived VEGF resulted in significant inhibition of ischaemia-induced retinal neovascularisation and vascular leakage strongly suggests that retinal Müller cell-derived VEGF is a major contributor to retinal neovascularisation . However, VEGF production is regulated by multiple transcription factors in addition to HIF-1. To determine the role of HIF-1 produced in Müller cell in ischaemia-induced overproduction of VEGF and retinal neovascularisation, we generated conditional Hif-1α (also known as Hif1a) knockout (KO) mice using the cre (also known as P1_gp003)/lox system. This report describes our initial characterisation of Hif-1α KO mice in hypoxia and diabetes.
Generation of conditional Hif-1α KO mice and animal treatment
All animal experiments were performed following the guidelines of the Association for Research in Vision and Ophthalmology (ARVO) ‘Statement on the Use of Animals in Ophthalmic and Vision Research’ and approved by the Institutional Animal Care and Use Committee (Protocol 08-175 H1). Conditional Hif-1α KO mice were generated by mating Müller cell-expressing cre mice with floxed Hif-1α mice (electronic supplementary material [ESM] Fig. 1a) [15, 19]. Genotyping was performed using primers with sequences 5′-GCAGTTAAGAGCACTAGTTG-3′ and 5′-GGAGCTATCTCCTAGACC-3′ to detect a 220 bp product from the wild-type allele and a 280 bp product for the floxed Hif-1α allele (ESM Fig. 1b) . PCR for cre was performed using primers 5′-AGGTGTAGAGAAGGCACTTAGC-3′ and 5′-CTAATCGCCATCTTCCAGCAGG-3′ to detect a 411 bp product (ESM Fig. 1b) . Hif-1α disruption in the Hif-1α KO mice was induced by feeding doxycycline at a dose of 2 mg/ml in 5% (wt/vol.) sucrose solution from embryonic day 15 to postnatal day 1 (P1).
Oxygen-induced retinopathy (OIR) was generated by placing mice in 75% (vol./vol.) oxygen from P7 to P12 and then returning them to room air. Diabetes was induced in 8- to 10-week-old male mice (19–24 g) by five daily intraperitoneal injections of streptozotocin (Sigma, St Louis, MO, USA) in 10 mmol/l citrate buffer (pH 4.5), at a dose of 55 mg/kg body weight after fasting for 8 h. Age-matched controls received citrate buffer. Fasting blood glucose was measured 1 week after the last injection of streptozotocin and every 2 weeks thereafter. Only mice maintaining glucose levels >16.65 mmol/l for 2 months were used for this study. No insulin was given to the diabetic mice.
Primary Müller cell culture
Primary Müller cells were cultured as described previously [15, 20]. The retinas were isolated, minced into ~1 mm2 fragments and cultured in DMEM with 10% (vol./vol.) FBS and 1% (wt/vol.) penicillin/streptomycin. After the cultures had been maintained for 3 days in 5% (vol./vol.) CO2 at 37°C, the retinal aggregates were removed. Serum-free DMEM medium was applied before further analysis. Cultured cells of fourth to sixth passages were used.
Electroretinogram (ERG) measurement was performed as described previously . Dark adaptation time was 12 h, light adaption time 15 min. The flash intensities were 1,000 and 2,000 cd s−1 m2. The duration of light stimulation was 10 ms. The band pass was set at 0.3 to 500 Hz. For quantitative analysis, the B-wave amplitude was measured between the peaks of A- and B-waves. The ERG waveforms of both eyes in the same animal were simultaneously recorded.
Retinal morphology examination
Eyes were fixed for 48 h, embedded in paraffin and sectioned (5 μm thickness). Sections were stained with haematoxylin and eosin, and examined under a light microscope. Morphometric analysis of retinal sections was performed as described previously .
Western blot analysis
Western blot analysis was performed as described previously [23, 24]. The protein concentration was determined using the Bradford assay. Mouse anti-β-actin antibody (1:4,000 dilution; Abcam, Cambridge, MA, USA), goat anti-albumin antibody (1:3,000 dilution; Bethyl Laboratories, Montgomery, TX, USA), rabbit anti-HIF-1α antibody (NB100-479, 1:2,000 dilution; Novus Biologicals, Littleton, CO, USA), rabbit anti-TNF-α antibody (1:2,500 dilution; Abcam), mouse anti-VEGF antibody (C15, 1:500 dilution; Santa Cruz Biotechnologies, Santa Cruz, CA, USA) and mouse anti-intercellular adhesion molecule (ICAM)-1 antibody (1:500 dilution; Santa Cruz) were used to detect each protein and blotted with a horseradish peroxidase-conjugated secondary antibody. The signal was developed with Super Signal West Dura extended duration substrate (Thermo Scientific, Rockford, IL, USA) and images captured by an image station (Chemi Genius; SynGene, Frederick, MD, USA). Blots were then stripped and re-blotted with an antibody specific for β-actin.
Eyecups were treated for 15 min in 4% (wt/vol.) paraformaldehyde, then with 10% (wt/vol.), 20% (wt/vol.) and 30% (wt/vol.) sucrose, and embedded in optimal cutting temperature compound (Tissue-Tek; Sakura Finetek, Torrance, CA, USA). Sections were cut and blocked with 10% (vol./vol.) normal goat serum, 3% (wt/vol.) BSA and 0.25% (vol./vol.) Triton X-100. Slides were incubated with the anti-HIF-1α antibody (NB 100–479, 1:100 dilution; Novus Biologicals) or an anti-VEGF antibody (C15; 1:50 dilution; Santa Cruz), and double-stained with a rabbit anti-glutamine synthetase (GS) antibody (1:1,000 dilution; Abcam). The slides were then incubated for 1 h with Cy3- and FITC-labelled secondary antibodies (Jackson ImmunoResearch Europe, Newmarket, UK), and mounted with a mounting medium for fluorescence with DAPI (Vector Laboratories, Burlingame, CA, USA). For in vitro assay, the cells were fixed with 4% paraformaldehyde for 10 min and incubated with 0.1% (vol./vol.) Triton X-100. The fixed cells were stained with an anti-GS (1:10,000 dilution) or an anti-HIF-1α antibody (NB 100-479, 1:1,000 dilution).
ELISA for VEGF
A commercial mouse VEGF ELISA kit (R&D Systems, Minneapolis, MN, USA) was used according to the manufacturer’s instruction to measure VEGF levels, with results normalised to total protein concentrations.
Retinal angiography was performed as described previously . For analysis of the retinal vessel density in mice under normal conditions, angiographic images were used to count the mean microvessel intersections, as described [15, 26].
Quantification of retinal neovascularisation
Pre-retinal neovascularisation was quantified as described previously . Retinal sections with haematoxylin and eosin staining were examined under a light microscope. All nuclei found on the vitreal side of the inner limiting membrane were considered vascular cells, as in normal conditions few nuclei can be found in the vitreous on a cross-section. Eight discontinuous sections per eye were used to quantify pre-retinal vascular cells.
The assay was performed as described previously . Briefly, mice were perfused through the left ventricle to remove circulating leucocytes in blood vessels. The adherent leucocytes in the vasculature were stained by perfusion with FITC-conjugated concanavalin-A (40 μg/ml; Vector Laboratories) and counted.
The quantitative data were analysed and compared with those from wild-type mice using unpaired Student’s t test (two-tailed test). Statistical significance was set at p < 0.05.
Disrupting Hif-1α in Müller cells from conditional Hif-1α KO mice
Western blot analysis demonstrated that HIF-1α levels were decreased significantly in primary Müller cells derived from Hif-1α KO mice under normoxia compared with their wild-type counterparts (Fig. 1p). Exposure of wild-type cells to hypoxia upregulated HIF-1α levels significantly (p < 0.01; Fig. 1p). In contrast, hypoxia-induced increase of HIF-1α production was partially attenuated in cells from Hif-1α KO mice.
Similarly, abundance of VEGF, a target of HIF-1, was significantly induced by hypoxia in wild-type Müller cells, but not in those from Hif-1α KO mice (Fig. 1q).
Retinal development in the Hif-1α KO mice
Decreased retinal levels of HIF-1α in the retina of Hif-1α KO mice
Hif-1α KO prevented ischaemia-induced overabundance of VEGF
Retinal inflammation and vascular leakage were attenuated in OIR-treated Hif-1α KO mice
To evaluate vascular leakage, serum albumin was measured in the retina after removal of albumin in the vasculature by thorough perfusion. Western blot analysis showed that retinal albumin was significantly increased by OIR in wild-type mice (Fig. 5b), a finding consistent with previous reports that OIR increases vascular permeability in the retina . However, the elevation of retinal albumin was attenuated in Hif-1α KO mice, suggesting an essential role of Müller cell-derived HIF-1α in ischaemia-induced vascular leakage (Fig. 5b).
Attenuation of ischaemia-induced retinal neovascularisation in Hif-1α KO mice
Disruption of the Hif-1α gene in Müller cells attenuated retinal inflammation and vascular leakage induced by diabetes
Disruption of the Hif-1α gene in Müller cells inhibited diabetes-induced leucostasis
Diabetic retinopathy is a common microvascular complication of diabetes [28, 29]. Retinal neovascularisation, vascular leakage and retinal oedema are common pathogenic features in diabetic retinopathy and major causes of vision loss in patients with diabetes . Diabetic retinopathy is a multi-factorial disorder. Clinical and experimental observations indicate that hypoxia or ischaemia are major driving forces of this pathological process . HIF-1α is the key regulator mediating the responses to hypoxia [30, 31]. Multiple proteins regulated by HIF-1α have been implicated in the pathogenesis of diabetic retinopathy, including VEGF, placental growth factor, stromal-derived factor 1, angiopoietin 2, platelet-derived growth factor B and erythropoietin . To date, anti-VEGF therapies have demonstrated their usefulness in treating ocular neovascularisation, but they only improve vision in less than 50% of treated patients, suggesting that pathogenic factors other than VEGF may also play an important role in non-responders. More and more evidence indicates that no single growth factor acts alone to cause retinal neovascularisation [4, 33]. It is therefore crucial to identify an upstream regulator that regulates multiple pathogenic factors, not only to improve understanding of how diabetic retinopathy develops, but also to uncover new potential therapeutic targets. HIF-1 is a transcription factor regulating multiple angiogenic and inflammatory factors . However, conclusive evidence of a pathogenic role of HIF-1 in diabetic retinopathy has not been obtained. The present study established a Müller cell-specific Hif-1α KO mouse model. In addition, it has shown for the first time that HIF-1α in Müller cells is essential for ischaemia- and diabetes-induced retinal inflammation, vascular leakage and neovascularisation, suggesting that HIF-1α is a promising candidate as an upstream drug target.
Although it is well known that HIF-1 mediates an orchestrated expression of angiogenic factors in multiple cell types within the ischaemic tissue in a temporally and spatially regulated manner , the major cellular location of HIF-1 accumulation in diabetic retina was virtually unknown. Retinal Müller cells are the major supporting glial cells contacting and ensheathing every type of neuronal cell body and process . The role of retinal Müller cells in retinal neovascularisation was speculated on in 1995, in a study suggesting that retinal Müller cells are the major source of VEGF in patients with retinal neovascularisation . In diabetic retinopathy, overproduction of angiogenic factor occurs mainly in the inner retinal cells such as Müller cells . However, the role of growth factor overproduction driven by HIF-1 in Müller cells has not been established. Previous research has shown that disruption of Müller cell-derived VEGF in conditional Vegf (also known as Vegfa) KO mice with an inducible Cre/lox system significantly inhibited ischaemia-induced retinal neovascularisation, vascular leakage and breakdown of the blood-retina barrier, further suggesting that retinal Müller cell-derived VEGF is a major contributor to ischaemia-induced retinal vascular leakage and pre-retinal and intra-retinal neovascularisation .
With the same inducible Cre/lox system  we generated Müller cell-specific Hif-1α KO mice and demonstrated that the loss of Müller cell-derived HIF-1α did not significantly reduce expression of Vegf and other HIF-1α target genes under normoxic conditions. To study the role of HIF-1 in Müller cells in response to stress conditions, Hif-1α KO mice were subjected to ischaemia-induced retinal neovascularisation and diabetes. These experiments showed that Hif-1α KO in Müller cells significantly attenuated ischaemia-induced retinal neovascularisation. Disruption of Hif-1α in Müller cells also reduced ischaemia- or diabetes-induced retinal inflammation and vascular leakage. These observations suggest that HIF-1 produced in Müller cells plays a key role in retinal neovascularisation and vascular leakage in diabetic retinopathy. This finding not only provides new insights into the pathogenesis of diabetic retinopathy, but may also contribute to the development of cell-based therapeutics for diabetic retinopathy.
Chronic retinal inflammation has been shown to play a major pathogenic role in diabetic retinopathy . Overabundance of ICAM-1 has been found in diabetic retinopathy and plays an important role in leucocyte adherence to the vasculature . The present study shows that ICAM-1 overabundance in models of diabetic retinopathy is suppressed in Hif-1α KO mice. This downregulation may contribute to the amelioration of leucostasis in the diabetic retina. Although the mechanism by which HIF-1 regulates ICAM-1 remains to be elucidated, these results suggest that HIF-1α in Müller cells is also an important mediator of retinal inflammation in diabetic retinopathy.
OIR is a commonly used model of ischaemia-induced retinal neovascularisation [2, 38]. Although it is not a diabetic model, its pathology, i.e. pre-retinal neovascularisation and pathogenesis, e.g. via overproduction of VEGF, is similar to that of proliferative diabetic retinopathy. It is therefore accepted as a model of proliferative diabetic retinopathy. With this OIR model, our wild-type mice showed accumulation of HIF-1α, and overproduction of VEGF and ICAM-1 in the retina, and also developed severe vascular leakage and pre-retinal neovascularisation. In contrast, in Müller cell-specific Hif-1α KO mice, increases of HIF-1α, VEGF, ICAM-1 and albumin in the retina were attenuated. Consistent with the decrease of multiple HIF-1α-regulated angiogenic factors, numbers of retinal neovascular tufts and pre-retinal vascular cells, as well as retinal vascular leakage, were significantly reduced in Hif-1α KO mice with OIR, suggesting that disruption of HIF-1α in Müller cells significantly blocks ischaemia-induced retinal neovascularisation and retinal vascular leakage.
It has been reported that HIF-1α is upregulated in diabetic retinas, and that the accumulation and nuclear translocation of HIF-1α result in overexpression of target genes such as Vegf [39–41]. There is some controversy regarding HIF-1 levels in the retina of animal models of diabetic retinopathy . The disparities are likely to be due to different hyperglycaemia levels, different duration of diabetes and different animal strains . In our study, accumulation of HIF-1α in diabetic retinas was also observed in a streptozotocin-induced model of diabetes. Consistent with the increase of HIF-1α, VEGF and ICAM-1 in the diabetic retinas were significantly upregulated. As a result, retinal levels of albumin and levels of adherent leucocytes in diabetic retinas were elevated, indicating that inflammation occurred and developed in our model. Disruption of the Hif-1α gene in retinal Müller cells alleviated retinal inflammation and vascular leakage in diabetic Hif-1α KO mice, suggesting that Müller cell-derived HIF-1α is an important contributor to diabetic retinopathy.
Since gene knockout using the cre/loxp system needs to be enhanced by doxycycline and cre-mediated recombination is not 100%, conditional gene KO does not usually disrupt the gene in every targeted cell [15, 44]. As a result, the Hif-1α KO efficiency must be confirmed before analysis of target gene expression. Our results in cultured Müller cells and in the retina both confirmed a significant reduction of HIF-1α levels in Hif-1α KO mice. Moreover, recent research implies that HIF-1α, VEGF and erythropoietin all have neurotrophic activities [18, 45]. Our studies showed that no apparent difference in retinal VEGF levels was detectable between wild-type and Hif-1α KO mice, possibly because other transcription factors such as activator protein 1, specificity protein 1, Akt, nitric oxide and cytokines can compensate for HIF-1 function . As a result, retinal morphology and function remained normal after knockout of Hif-1α in Müller cells. This notion suggests strategies blocking HIF-1 in the treatment of diabetic retinopathy are likely to be safe.
Although we demonstrated that Müller cell-derived HIF-1α was important for retinal inflammation and neovascularisation, our results do not exclude the possibility that other transcription factors are also involved in these processes. HIF-1α may be regulated by multiple factors besides hypoxia, such as nitric oxide, reactive oxygen species, sirtuin 1 and nuclear factor kappa B . Hyperglycaemia has been shown to regulate HIF-1α protein stability by interfering with its proteasome degradation . In addition, recent work has indicated that HIF-2 may be another important transcription factor that is upregulated in retinas with OIR and diabetic retinopathy . Further research with this conditional Hif-1α KO mouse model will facilitate our understanding of the relationship between these signalling pathways.
In summary, the present study provides the first evidence showing that Müller cell-derived HIF-1α is a pivotal contributor to diabetes- or ischaemia-induced retinal inflammation, vascular leakage and neovascularisation. Targeting HIF-1α in Müller cells could be a new therapeutic strategy for the treatment of retinal vascular diseases.
The authors would like to thank I. Blader at University of Oklahoma Health Sciences Center for assistance with Hif-1a/floxp mice. This study was supported by National Institutes of Health grants EY018659, EY019309, EY20900 and P20RR024215, and by grants from the ADA, Foundation Fighting Blindness and Guangdong Natural Science Fund (grant GDNSF05001713).
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.